BudProfiles
Home
Strains
Research
Conditions
Breeders
Compare
Explorer
Blog
Search...
Ctrl K
Toggle theme
Command Palette
Search for a command to run...
Research Database
24 studies found
Positive
22
91.7%
Negative
1
4.2%
Inconclusive
1
4.2%
Page 1 of 2
Negative
Review/Other
A Case of Panic Attacks Developing After 10 Years of Chronic Cannabis Use in a Patient With No Prior Psychiatric History
2023
Anxiety
Cannabis Adverse Effects
Cancer
+14
Inconclusive
Clinical Trial
Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis
2023
Skin Diseases
Positive
Review/Other
Cannabinoids for the Treatment of Dermatologic Conditions
2022
Compulsive hair pulling
Positive
Laboratory Study -
Molecular Mechanisms for the Inflammation-Resolving Actions of Lenabasum
2021
Inflammation
Positive
Review/Other
From a Designer Drug to the Discovery of Selective Cannabinoid Type 2 Receptor Agonists with Favorable Pharmacokinetic Profiles for the Treatment of Systemic Sclerosis
2021
Systemic Sclerosis
Positive
Review/Other
Cannabis and the skin
2021
Acne
Positive
Clinical Trial
Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic Sclerosis
2020
Systemic Sclerosis
Positive
Review/Other
Cannabinoid derivatives acting as dual PPARγ/CB2 agonists as therapeutic agents for systemic sclerosis
2019
Systemic Sclerosis
Positive
Review/Other
VCE‐004.3, a cannabidiol aminoquinone derivative, prevents bleomycin‐induced skin fibrosis and inflammation through PPARγ‐ and CB2 receptor‐dependent pathways
2019
Fibrosis - Skin
Positive
Review/Other
Cannabis sativa as a Potential Treatment for Systemic Sclerosis
2019
Cancer
Positive
Review/Other
EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis
2018
Fibrosis - Skin
Positive
Review/Other
Potent Anti-Inflammatory and Pro-Resolving Effects of Anabasum in a Human Model of Self-Resolving Acute Inflammation
2018
Inflammation
Positive
Review/Other
Cannabinoids in dermatology: a scoping review.
2018
Eczema
Positive
Review/Other
The Therapeutic Potential of Cannabinoids in Dermatology
2018
Skin Diseases
Positive
Review/Other
The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways.
2016
Systemic Sclerosis
Positive
Review/Other
A CB2-Selective Cannabinoid Suppresses T-cell Activities and Increases Tregs and IL-10
2016
Organ Transplant Failure
Positive
Review/Other
Effects of Cannabinoids on T-cell Function and Resistance to Infection.
2015
Arthritis
Positive
Review/Other
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system.
2012
Systemic Sclerosis
Positive
Review/Other
Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1
2012
Fibrosis - Skin
Positive
Review/Other
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis.
2012
Fibrosis - Lung
1
2
Next
Systemic Sclerosis
Epidermolysis bullosa
Inflammation
+2
Lupus
Systemic Sclerosis
Cancer - Melanoma
Cancer - Skin (Non-melanoma)
+11
Inflammation
Inflammation
Fibrosis
Inflammation
+1
Multiple Sclerosis
Pain
+3
Fibrosis
Systemic Sclerosis
+1
Fibrosis
Lupus
+1
Acne Inversa
Acne
+8
Acne
Cancer - Skin (Non-melanoma)
+3
Dupuytren's Contracture
IBD - Inflammatory Bowel Disease
Inflammation
+6
Arthritis - Rheumatoid
Bacterial Infections
+3
Fibrosis
Systemic Sclerosis
Inflammation
Systemic Sclerosis